Login

Dr. Peter Suzdak, CEO of Rexahn Pharmaceuticals 00:00:00

Share On Facebook Share On Twitter

Corporate Profile interviews Dr. Peter Suzdak, CEO of Rexahn Pharmaceuticals (RNN)

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
John Baffers, Senior Economist at the World Bank: Global Commodity Markets Outlook and Economic Trends
00:10:00
WisdomTree is a global financial innovator, offering a well-diversified suite of exchange-traded products (ETPs), models, solutions and products leveraging blockchain technology. We empower investors and consumers to shape their future and support financi
00:10:00
KSN Mining Unveils $100 Million Workshop Investment in Augusta
00:10:00
Public Expose PT Visi Media Asia Tbk. | Omar Luthfi Anwar, CEO, Visi Media Asia Tbk PTVIVA:JKT
00:10:00
Join Tempest Minerals' Investor Hub for Direct Updates and Engagement
00:10:00
dedicated team is made up of seasoned investors who are looking to partner with hard-working|Ali Jamal,Founding Partner,First Check Ventures
00:10:00
Barclays CEO Talks Business Optimization and Investment Banking Strength | C.S. Venkatakrishnan , CEO , Barclays.
00:10:00
"Global and Emerging Markets Outlook with Mark Mobius | Voyage 2022"
00:10:00
Embracing Retirement: Leveraging Skills and Flexibility in the Gig Economy
00:10:00
GSFM Conversations: Unpacking Absolute Return Bond Funds with Eric Souders | Eric Souders, Portfolio Manager, Payden Global Income Opportunities Fund
00:10:00
Skillz CEO Andrew Paradise discusses the company's plan to go public.
00:10:00
Al Gore's Insights on Climate Action and Democracy | Al Gore , Chairman , Generation Investment Management.

© 2017 - Neuhu+